Condition: Familial Hypercholesterolemia · Sponsor: Odense University Hospital
Familial hypercholesterolemia is the most common inherited disease of the lipid metabolism, however it remains underdiagnosed. Only 15 % of 30.000 possible patients have been found in Denmark. This quality assessing project will through a step wedge cluster randomized controlled trial evaluate establishment of a biochemistry interpretive comment on elevated LDL-C levels. The study will test if the comment results in an increase in referred patients to the lipid clinics of Southern Denmark as the primary endpoint, and as the secondary endpoint in more patients diagnosed with familial hypercholesterolemia. The project will run in totally 52 weeks and will in steps initiate the comment from the different laboratories in the Region of Southern Denmark.
This description comes directly from the study's public registry record.
Jakob Knold, MD · 004541278928 · jakobknold@rsyd.dk
Finn Lund Henriksen, Ph.d. · 29679722 · finn.l.henriksen@rsyd.dk
Always discuss trial participation with your own doctor first.
| Odense University Hospital | Odense, Funen, Denmark | Recruiting |
| Departement of Cardiology, Odense University Hospital | Odense C, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05614219